NCT05857449View on ClinicalTrials.gov

An Exploratory Study of LPM3480392 at Different Infusion Rates in Chinese Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 8, 2021

Primary Completion Date

March 9, 2022

Study Completion Date

March 9, 2022

Conditions
Healthy
Interventions
DRUG

LPM3480392

Intravenous infusion

Trial Locations (1)

310000

The second affiliated hosipital zhejiang university school of medicine, Hangzhou

All Listed Sponsors
lead

Luye Pharma Group Ltd.

INDUSTRY

NCT05857449 - An Exploratory Study of LPM3480392 at Different Infusion Rates in Chinese Healthy Subjects | Biotech Hunter | Biotech Hunter